应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DGX 奎斯特诊疗
交易中 07-25 10:26:08 EDT
170.48
-1.41
-0.82%
最高
173.04
最低
170.24
成交量
17.78万
今开
172.91
昨收
171.90
日振幅
1.63%
总市值
190.64亿
流通市值
189.66亿
总股本
1.12亿
成交额
3,040万
换手率
0.16%
流通股本
1.11亿
市净率
2.64
ROE
14.26%
每股收益
8.35
52周最高
182.38
52周最低
140.71
市盈率
20.43
股息
3.10
股息收益率
0.02
ROA
6.34%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
奎斯特诊疗2025财年第二财季实现净利润2.81亿美元,同比增加23.25%
市场透视 · 07-22 23:00
奎斯特诊疗2025财年第二财季实现净利润2.81亿美元,同比增加23.25%
异动解读 | 业绩超预期且上调全年指引,奎斯特诊疗盘中大涨5.02%
异动解读 · 07-22
异动解读 | 业绩超预期且上调全年指引,奎斯特诊疗盘中大涨5.02%
消息称基于 GB10 的英伟达 DGX Spark 相关终端本月起上市开卖
市场资讯 · 07-08
消息称基于 GB10 的英伟达 DGX Spark 相关终端本月起上市开卖
消息称英伟达首款面向消费者AI超级计算机DGX Spark下月前推出 起售价约4000美元
IT之家 · 06-02
消息称英伟达首款面向消费者AI超级计算机DGX Spark下月前推出 起售价约4000美元
黄仁勋:将与台积电、富士康在台湾共同生产AI超级计算机 DGX Spark已全面投产
新浪科技 · 05-19
黄仁勋:将与台积电、富士康在台湾共同生产AI超级计算机 DGX Spark已全面投产
奎斯特诊疗2025财年第一财季实现净利润2.19亿美元,同比增加13.47%
市场透视 · 04-24
奎斯特诊疗2025财年第一财季实现净利润2.19亿美元,同比增加13.47%
Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由182.00美元调整至190.00美元。
金融界 · 04-23
Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由182.00美元调整至190.00美元。
异动解读 | 奎斯特诊疗季度业绩超预期,股价盘中大涨5.44%
异动解读 · 04-22
异动解读 | 奎斯特诊疗季度业绩超预期,股价盘中大涨5.44%
奎斯特诊疗盘中异动 早盘股价大涨5.44%
市场透视 · 04-22
奎斯特诊疗盘中异动 早盘股价大涨5.44%
异动解读 | 奎斯特诊疗季度业绩超预期,盘前股价大涨5.03%
异动解读 · 04-22
异动解读 | 奎斯特诊疗季度业绩超预期,盘前股价大涨5.03%
瑞穗银行:维持Quest Diagnostics(DGX.US)评级,由优于大市调整至优于大市评级, 目标价由177.00美元调整至178.00美元。
金融界 · 02-03
瑞穗银行:维持Quest Diagnostics(DGX.US)评级,由优于大市调整至优于大市评级, 目标价由177.00美元调整至178.00美元。
Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由172.00美元调整至182.00美元。
金融界 · 01-31
Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由172.00美元调整至182.00美元。
奎斯特诊疗2024财年实现净利润8.66亿美元,同比增加1.88%
市场透视 · 01-31
奎斯特诊疗2024财年实现净利润8.66亿美元,同比增加1.88%
巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由168.00美元调整至175.00美元。
金融界 · 01-31
巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由168.00美元调整至175.00美元。
异动解读 | 奎斯特诊疗2024年Q4财报表现出色,盘中股价大涨5.1%
异动解读 · 01-30
异动解读 | 奎斯特诊疗2024年Q4财报表现出色,盘中股价大涨5.1%
奎斯特诊疗盘中异动 早盘大幅上涨5.25%报163.60美元
市场透视 · 01-30
奎斯特诊疗盘中异动 早盘大幅上涨5.25%报163.60美元
Quest Diagnostics(DGX.US):2024年Q4财报实现营收26.21亿美元,前值为22.88亿美元,预期值为25.8亿美元;每股收益为2.23美元,前值为2.15美元,预期值为2.18美元。
金融界 · 01-30
Quest Diagnostics(DGX.US):2024年Q4财报实现营收26.21亿美元,前值为22.88亿美元,预期值为25.8亿美元;每股收益为2.23美元,前值为2.15美元,预期值为2.18美元。
Quest Diagnostics 2024年第四季度调整后每股收益$2.23,超过预期的$2.19,销售额为$26.2亿,超过预期的$25.8亿
财报速递 · 01-30
Quest Diagnostics 2024年第四季度调整后每股收益$2.23,超过预期的$2.19,销售额为$26.2亿,超过预期的$25.8亿
【券商聚焦】摩根士丹利:北美医疗保健服务行业MA预期改善 个股目标价及评级各有调整
金吾财讯 · 2024-12-18
【券商聚焦】摩根士丹利:北美医疗保健服务行业MA预期改善 个股目标价及评级各有调整
加载更多
公司概况
公司名称:
奎斯特诊疗
所属市场:
NASDAQ
上市日期:
1996-12-17
主营业务:
奎斯特诊疗公司于1990年在特拉华州成立。公司是全球领先的诊断信息服务提供商。公司在医疗生态系统中扮演着至关重要的角色,使人们能够采取行动改善健康状况。来自世界上最大的临床实验室结果数据库,其诊断见解揭示了识别和治疗疾病、激励健康行为和改善医疗管理的新途径。在正确的人和正确的背景下,它的诊断性见解可以激发改变生活的行动。
发行价格:
--
{"stockData":{"symbol":"DGX","market":"US","secType":"STK","nameCN":"奎斯特诊疗","latestPrice":170.48,"timestamp":1753453561380,"preClose":171.895,"halted":0,"volume":177746,"delay":0,"floatShares":111250021,"shares":111823441,"eps":8.346255,"marketStatus":"交易中","change":-1.415,"latestTime":"07-25 10:26:02 EDT","open":172.905,"high":173.04,"low":170.24,"amount":30401032.39948,"amplitude":0.016289,"askPrice":170.44,"askSize":4,"bidPrice":170.23,"bidSize":178,"shortable":3,"etf":0,"ttmEps":8.346255,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753473600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":850798800000,"exchange":"NASDAQ","adjPreClose":171.895,"dividendRate":0.018184,"preHourTrading":{"tag":"盘前","latestPrice":175,"preClose":171.895,"latestTime":"09:13 EDT","volume":38234,"amount":6572519.03798,"timestamp":1753449200236},"postHourTrading":{"tag":"盘后","latestPrice":171.9,"preClose":171.9,"latestTime":"19:53 EDT","volume":38778,"amount":6665989.4,"timestamp":1753401228549},"volumeRatio":0.530801,"impliedVol":0.1997,"impliedVolPercentile":0.084},"requestUrl":"/m/hq/s/DGX","defaultTab":"news","newsList":[{"id":"2553269463","title":"奎斯特诊疗2025财年第二财季实现净利润2.81亿美元,同比增加23.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553269463","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553269463?lang=zh_cn&edition=full","pubTime":"2025-07-23 07:00","pubTimestamp":1753225223,"startTime":"0","endTime":"0","summary":"7月23日,奎斯特诊疗公布财报,公告显示公司2025财年第二财季净利润为2.81亿美元,同比增加23.25%;其中营业收入为27.61亿美元,同比增加15.19%,每股基本收益为2.51美元。从资产负债表来看,奎斯特诊疗总负债86.23亿美元,其中短期债务6.75亿美元,资产负债比为1.86,流动比率为1.09。机构评级:截至2025年7月23日,当前有16家机构对奎斯特诊疗目标价做出预测,其中目标均价为187.44美元,其中最低目标价为160.00美元,最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723070036a6bbcd34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723070036a6bbcd34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DGX"],"gpt_icon":0},{"id":"1147993286","title":"异动解读 | 业绩超预期且上调全年指引,奎斯特诊疗盘中大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147993286","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147993286?lang=zh_cn&edition=full","pubTime":"2025-07-22 21:52","pubTimestamp":1753192354,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中大涨5.02%,股价表现引人注目。此次上涨主要受到公司发布的第二季度财报以及上调全年业绩指引的利好消息推动。据公司公布的财报显示,奎斯特诊疗第二季度调整后每股收益为2.62美元,高于分析师平均预期的2.57美元。更为重要的是,奎斯特诊疗上调了2025年全年业绩指引。公司首席执行官吉姆·戴维斯表示,奎斯特诊疗在继续部署自动化和数字技术的同时,实现了生产率的提高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"gpt_icon":0},{"id":"2549559945","title":"消息称基于 GB10 的英伟达 DGX Spark 相关终端本月起上市开卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2549559945","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549559945?lang=zh_cn&edition=full","pubTime":"2025-07-08 11:51","pubTimestamp":1751946660,"startTime":"0","endTime":"0","summary":"IT之家 7 月 8 日消息,台媒《经济日报》今日凌晨报道称,英伟达规划全球主要 PC 品牌大厂及各地通路 合作伙伴将自 7 月起开始供货 DGX Spark 相关产品并上市开卖。华硕此前已宣布其基于DGX Spark 的第三方化设备 Ascent GX10 的网络发布研讨会将在北京时间 7 月 22 日举行,而根据IT之家了解英伟达 DGX Spark 的第一方版本也有望于 7~8 月到货中国大陆市场。据悉英伟达的 DGX Spark 已吸引到宏碁、华硕、戴尔、技嘉、惠普、联想、微星等一系列 PC 企业的合作。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-07-08/doc-infetqhr5426490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2083900584.USD","LU1244550221.USD","LU1633808545.USD","LU1699723380.USD","LU0642271901.SGD","LU2063271972.USD","LU1242518857.USD","LU2361044949.HKD","LU2458330169.SGD","LU1280957306.USD","LU2242650005.HKD","BK4567","LU1951200564.SGD","LU2249611893.SGD","BK4585","LU2430703251.USD","LU0417517546.SGD","BK4583","IE00BHPRN162.USD","NVD2.UK","LU1934455194.USD","IE00BKDWB100.SGD","NVDS.UK","3NVD.UK","LU1720051108.HKD","NVDA","NVDX","NVD3.UK","NVDY","LU2092937148.SGD","LU2491049909.HKD","NVDD","DGX","NVDS","LU2456880835.USD","IE00B1BXHZ80.USD","NVIW.SI","NVD","SNVD.UK","IE00BMPRXN33.USD","LU0251132253.USD","BK4592","2NVD.UK","LU2552382058.USD","LU1852331112.SGD","LU0069063385.USD","NVDU","LU0964807845.USD","LU2247934214.USD"],"gpt_icon":1},{"id":"2540112577","title":"消息称英伟达首款面向消费者AI超级计算机DGX Spark下月前推出 起售价约4000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540112577","media":"IT之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540112577?lang=zh_cn&edition=full","pubTime":"2025-06-03 07:53","pubTimestamp":1748908401,"startTime":"0","endTime":"0","summary":"【消息称英伟达首款面向消费者AI超级计算机DGX Spark下月前推出 起售价约4000美元】据台媒经济日报报道,英伟达旗下首款面向消费者的 AI 超级计算机 DGX Spark 预计将在今年 7 月(下月)前推出,起售价约为 4000 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202506033420022247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1119994496.HKD","LU0308772762.SGD","LU1720051017.SGD","LU2552382132.HKD","LU0256863811.USD","IE00BD6J9T35.USD","LU2491050071.SGD","HK0000320223.HKD","BK4551","IE00BN29S564.USD","LU0265550359.USD","NVD2.UK","LU0203201768.USD","LU2433249047.HKD","LU2168564495.EUR","LU1037948897.HKD","NVDS.UK","3NVD.UK","BK4550","LU0444971666.USD","NVDA","SG9999000418.SGD","LU0640476718.USD","BK4614","BK4549","NVD3.UK","SGXZ51526630.SGD","NVDY","LU2237957811.SGD","NVDD","LU2097344431.USD","DGX","LU1951198990.SGD","NVDS","LU1861215975.USD","BK4608","LU2244417387.USD","NVIW.SI","SNVD.UK","LU0868494708.USD","LU1868837136.USD","LU2471134879.HKD","2NVD.UK","IE00BJJMRY28.SGD","LU1935043023.USD","NVDU","LU2463028550.USD"],"gpt_icon":1},{"id":"2536315527","title":"黄仁勋:将与台积电、富士康在台湾共同生产AI超级计算机 DGX Spark已全面投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2536315527","media":"新浪科技","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536315527?lang=zh_cn&edition=full","pubTime":"2025-05-19 12:16","pubTimestamp":1747628160,"startTime":"0","endTime":"0","summary":"新浪科技讯 5月19日上午消息,英伟达CEO黄仁勋在台北国际电脑展(Computex 2025)开幕式演讲中宣布,英伟达将与台积电、富士康在台湾共同生产AI超级计算机。\n 黄仁勋还谈到,个人AI计算机DGX Spark已全面投产,将于数周内就绪。DGX Spark搭载英伟达GB10超级芯片及张量核心。还推出DGX Station工作站,预计华硕、戴尔、惠普今年晚些时候将推出DGX Station工作站。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:曹睿潼","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/notebook/new/2025-05-19/doc-inexaksa7880956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2471134879.HKD","IE00BQXX3D17.EUR","NVDA","LU0310800379.SGD","LU0264606111.USD","LU2491049909.HKD","NVDD","LU2417539215.USD","LU1951198990.SGD","NVDS.UK","NVDS","NVD2.UK","3NVD.UK","LU0889565833.HKD","IE00B1XK9C88.USD","2NVD.UK","IE00BDCRKT87.USD","NVIW.SI","LU1721428933.USD","BK4503","NVD","LU2430703095.HKD","SNVD.UK","LU1366333091.USD","03145","LU1861215975.USD","TWmain","EWT","LU1316542783.SGD","LU2452424414.USD","LU1814569148.SGD","DGX","LU0964807845.USD","LU2294711713.HKD","IE00BKVL7J92.USD","LU0476273544.USD","LU1064131342.USD","LU2063271972.USD","NVDU","LU1778281490.HKD","LU1815336760.USD","GB00BDT5M118.USD","IE00BFXG0V08.USD","NVD3.UK","NVDY","LU0788109477.HKD","BK4533"],"gpt_icon":0},{"id":"2529291606","title":"奎斯特诊疗2025财年第一财季实现净利润2.19亿美元,同比增加13.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529291606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529291606?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:00","pubTimestamp":1745488827,"startTime":"0","endTime":"0","summary":"4月24日,奎斯特诊疗公布财报,公告显示公司2025财年第一财季净利润为2.19亿美元,同比增加13.47%;其中营业收入为26.52亿美元,同比增加12.09%,每股基本收益为1.97美元。从资产负债表来看,奎斯特诊疗总负债87.54亿美元,其中短期债务1.74亿美元,资产负债比为1.81,流动比率为1.44。机构评级:截至2025年4月24日,当前有16家机构对奎斯特诊疗目标价做出预测,其中目标均价为184.31美元,其中最低目标价为160.00美元,最高目标价为198.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424180033a6c66886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424180033a6c66886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DGX"],"gpt_icon":0},{"id":"2529658089","title":"Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由182.00美元调整至190.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529658089","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529658089?lang=zh_cn&edition=full","pubTime":"2025-04-24 00:52","pubTimestamp":1745427150,"startTime":"0","endTime":"0","summary":"Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由182.00美元调整至190.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24005249809448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DGX"],"gpt_icon":0},{"id":"1199179295","title":"异动解读 | 奎斯特诊疗季度业绩超预期,股价盘中大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199179295","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199179295?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:35","pubTimestamp":1745328922,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中股价大涨5.44%,主要受益于公司公布的第一季度业绩超出市场预期。根据公司最新发布的财报,奎斯特诊疗2025年第一季度调整后每股收益达2.21美元,高于分析师平均预期的2.15美元。值得注意的是,尽管季度业绩表现亮眼,奎斯特诊疗仍维持了其全年调整后每股收益预期,范围为9.55美元至9.80美元。这表明公司对未来业务发展保持谨慎乐观的态度。\"投资者对公司的稳健增长前景反应积极,推动股价上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"gpt_icon":0},{"id":"2529358654","title":"奎斯特诊疗盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529358654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529358654?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:33","pubTimestamp":1745328788,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时33分,奎斯特诊疗股票出现波动,股价急速拉升5.44%。截至发稿,该股报170.66美元/股,成交量4.854万股,换手率0.04%,振幅0.99%。奎斯特诊疗股票所在的生命科学行业中,整体涨幅为1.62%。其相关个股中,Precipio, Inc.、奎斯特诊疗、Endra Life Sciences Inc.涨幅较大,Applied Dna Sciences, Inc.、Endra Life Sciences Inc.、Medpace Holdings, Inc.较为活跃,换手率分别为2.60%、1.31%、0.34%,振幅较大的相关个股有Endra Life Sciences Inc.、万基遗传、Mainz Biomed N.V.,振幅分别为7.74%、3.65%、3.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221330994de329c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221330994de329c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4567","LU1854103824.USD","DGX","BK4585","LU1854104046.USD","BK4588","BK4196"],"gpt_icon":0},{"id":"1110428074","title":"异动解读 | 奎斯特诊疗季度业绩超预期,盘前股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110428074","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110428074?lang=zh_cn&edition=full","pubTime":"2025-04-22 19:52","pubTimestamp":1745322766,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘前股价大涨5.03%,主要受益于公司第一季度业绩超出市场预期。季度销售额同比增长12%,达到26.5亿美元,同样超过了分析师预估的26.3亿美元。强劲的业绩主要得益于诊断测试需求的增加,特别是来自美国老年人群体对此前推迟的非紧急手术相关检查的需求。\"值得注意的是,奎斯特诊疗维持了其全年调整后每股收益预期,范围为9.55美元至9.80美元。这表明公司对未来业务发展保持谨慎乐观的态度。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 奎斯特诊疗季度业绩超预期,盘前股价大涨5.03%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"gpt_icon":0},{"id":"2508512138","title":"瑞穗银行:维持Quest Diagnostics(DGX.US)评级,由优于大市调整至优于大市评级, 目标价由177.00美元调整至178.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508512138","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508512138?lang=zh_cn&edition=full","pubTime":"2025-02-04 02:19","pubTimestamp":1738606781,"startTime":"0","endTime":"0","summary":"瑞穗银行:维持Quest Diagnostics(DGX.US)评级,由优于大市调整至优于大市评级, 目标价由177.00美元调整至178.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04021947942438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161121","DGX"],"gpt_icon":0},{"id":"2508967767","title":"Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由172.00美元调整至182.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508967767","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508967767?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:33","pubTimestamp":1738341205,"startTime":"0","endTime":"0","summary":"Truist Securities:维持Quest Diagnostics(DGX.US)评级,由持有调整至持有评级, 目标价由172.00美元调整至182.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/01003347922409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DGX"],"gpt_icon":0},{"id":"2508964727","title":"奎斯特诊疗2024财年实现净利润8.66亿美元,同比增加1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508964727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508964727?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:00","pubTimestamp":1738339240,"startTime":"0","endTime":"0","summary":"2月1日,奎斯特诊疗公布财报,公告显示公司2024财年净利润为8.66亿美元,同比增加1.88%;其中营业收入为98.72亿美元,同比增加6.70%,每股基本收益为7.80美元。从资产负债表来看,奎斯特诊疗总负债92.57亿美元,其中短期债务7.75亿美元,资产负债比为1.75,流动比率为1.11。机构评级:截至2025年2月1日,当前有15家机构对奎斯特诊疗目标价做出预测,其中目标均价为176.67美元,其中最低目标价为160.00美元,最高目标价为190.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201000055abbe4c05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201000055abbe4c05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DGX"],"gpt_icon":0},{"id":"2507965630","title":"巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由168.00美元调整至175.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507965630","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507965630?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:28","pubTimestamp":1738333727,"startTime":"0","endTime":"0","summary":"巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由168.00美元调整至175.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/31222847921853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DGX"],"gpt_icon":0},{"id":"1104196404","title":"异动解读 | 奎斯特诊疗2024年Q4财报表现出色,盘中股价大涨5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104196404","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104196404?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:41","pubTimestamp":1738248110,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中股价大涨5.1%,报收于144.26美元。引发该股价大涨的主因是该公司2024年第四季度业绩表现优异,超出市场预期。根据财报显示,奎斯特诊疗第四季度营收同比增长14.6%至26.2亿美元,高于分析师预期的25.8亿美元;调整后每股收益2.23美元,也超出了分析师平均预期的2.19美元。业绩超预期的主要原因是消费者对于诊断测试需求强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"gpt_icon":0},{"id":"2507213826","title":"奎斯特诊疗盘中异动 早盘大幅上涨5.25%报163.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507213826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507213826?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:38","pubTimestamp":1738247883,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时38分,奎斯特诊疗股票出现波动,股价大幅拉升5.25%。截至发稿,该股报163.60美元/股,成交量9.0837万股,换手率0.08%,振幅5.63%。奎斯特诊疗股票所在的生命科学行业中,整体涨幅为3.80%。其相关个股中,Personalis, Inc.、赛默飞世尔、奎斯特诊疗涨幅较大,Mainz Biomed N.V.、Ispecimen Inc.、Check-Cap Ltd.较为活跃,换手率分别为1.04%、0.50%、0.19%,振幅较大的相关个股有Check-Cap Ltd.、Bioaffinity Technologies, Inc.、奎斯特诊疗,振幅分别为9.09%、6.28%、5.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223804a2345694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223804a2345694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","LU1854103824.USD","BK4585","BK4588","BK4196","DGX","LU1854104046.USD","BK4567"],"gpt_icon":0},{"id":"2507264426","title":"Quest Diagnostics(DGX.US):2024年Q4财报实现营收26.21亿美元,前值为22.88亿美元,预期值为25.8亿美元;每股收益为2.23美元,前值为2.15美元,预期值为2.18美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507264426","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507264426?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:54","pubTimestamp":1738238063,"startTime":"0","endTime":"0","summary":"Quest Diagnostics(DGX.US):2024年Q4财报实现营收26.21亿美元,前值为22.88亿美元,预期值为25.8亿美元;每股收益为2.23美元,前值为2.15美元,预期值为2.18美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30195447908900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DGX"],"gpt_icon":0},{"id":"1162229232","title":"Quest Diagnostics 2024年第四季度调整后每股收益$2.23,超过预期的$2.19,销售额为$26.2亿,超过预期的$25.8亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1162229232","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162229232?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:52","pubTimestamp":1738237951,"startTime":"0","endTime":"0","summary":"Quest Diagnostics 报告的季度每股收益为$2.23,超过分析师预期的$2.19,超出1.83%。相比去年同期销售额$22.9亿增长了14.55%。以上内容来自Benzinga Earnings专栏,原文如下:Quest Diagnostics reported quarterly earnings of $2.23 per share which beat the analyst consensus estimate of $2.19 by 1.83 percent. This is a 3.72 percent increase over earnings of $2.15 per share from the same period last year. The company reported quarterly sales of $2.62 billion which beat the analyst consensus estimate of $2.58 billion by 1.65 percent. This is a 14.55 percent i","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Quest Diagnostics 2024年第四季度调整后每股收益$2.23,超过预期的$2.19,销售额为$26.2亿,超过预期的$25.8亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX"],"gpt_icon":0},{"id":"2492942352","title":"【券商聚焦】摩根士丹利:北美医疗保健服务行业MA预期改善 个股目标价及评级各有调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2492942352","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492942352?lang=zh_cn&edition=full","pubTime":"2024-12-18 10:37","pubTimestamp":1734489456,"startTime":"0","endTime":"0","summary":"摩根士丹利对这一领域的评级为“与市场一致”。此外,对于医疗保健技术和提供商,摩根士丹利建议保持选择性,因为需求和政策不确定性混合。对于行业中一些公司,摩根士丹利给出了以下评级和预期:对于Elevance Health Inc,摩根士丹利将其评级从“跑赢大市”下调至“与大市同步”,目标价从551美元降至388美元。对于Accolade Inc,目标价从6美元降至5美元,维持“与大市同步”评级。对于Cardinal Health Inc,目标价从127美元升至136美元,维持“跑赢大市”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"283371","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","GDRX","CAH","AMWL","LFST","DGX","MA","ELV","HUM","ACCD","HCA","VEEV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.questdiagnostics.com","stockEarnings":[{"period":"1week","weight":0.0221},{"period":"1month","weight":-0.0445},{"period":"3month","weight":-0.0107},{"period":"6month","weight":0.107},{"period":"1year","weight":0.1945},{"period":"ytd","weight":0.1395}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0456},{"period":"3month","weight":0.1522},{"period":"6month","weight":0.0435},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"奎斯特诊疗公司于1990年在特拉华州成立。公司是全球领先的诊断信息服务提供商。公司在医疗生态系统中扮演着至关重要的角色,使人们能够采取行动改善健康状况。来自世界上最大的临床实验室结果数据库,其诊断见解揭示了识别和治疗疾病、激励健康行为和改善医疗管理的新途径。在正确的人和正确的背景下,它的诊断性见解可以激发改变生活的行动。","yearOnYearQuotes":[{"month":1,"riseRate":0.448276,"avgChangeRate":-0.008326},{"month":2,"riseRate":0.413793,"avgChangeRate":-0.00274},{"month":3,"riseRate":0.689655,"avgChangeRate":0.023063},{"month":4,"riseRate":0.689655,"avgChangeRate":0.070673},{"month":5,"riseRate":0.724138,"avgChangeRate":0.02954},{"month":6,"riseRate":0.655172,"avgChangeRate":0.02586},{"month":7,"riseRate":0.413793,"avgChangeRate":-0.008503},{"month":8,"riseRate":0.535714,"avgChangeRate":-0.006081},{"month":9,"riseRate":0.392857,"avgChangeRate":-0.007871},{"month":10,"riseRate":0.5,"avgChangeRate":-0.000869},{"month":11,"riseRate":0.821429,"avgChangeRate":0.032205},{"month":12,"riseRate":0.714286,"avgChangeRate":0.027179}],"exchange":"NASDAQ","name":"奎斯特诊疗","nameEN":"Quest Diagnostics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奎斯特诊疗,DGX,奎斯特诊疗股票,奎斯特诊疗股票老虎,奎斯特诊疗股票老虎国际,奎斯特诊疗行情,奎斯特诊疗股票行情,奎斯特诊疗股价,奎斯特诊疗股市,奎斯特诊疗股票价格,奎斯特诊疗股票交易,奎斯特诊疗股票购买,奎斯特诊疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}